L-R: American Committee CEO Marshall S. Levin, National Chair Ellen Merlo, Mid-Atlantic Regional Chair Pennie Abramson, and Gary Abramson.

Washington, D.C.—April 16, 2018—The American Committee for the Weizmann Institute of Science celebrated the return of its Washington, D.C. and Mid-Atlantic Office with a special event at the Embassy of Israel. The evening attracted about 65 local supporters of the Weizmann Institute, one of the world’s leading multidisciplinary research institutions located in Rehovot, Israel. After opening remarks by American Committee CEO Marshall S. Levin, National Chair Ellen Merlo discussed the significance of reestablishing the organization’s Mid-Atlantic Region. Reuven Azar, Deputy Head of Mission at the Embassy of Israel, then welcomed guests, and illustrated the power of scientific cooperation to build bridges between Israel and other nations.

Following an introduction by Mid-Atlantic Regional Chair Pennie Abramson, renowned Weizmann scientist Prof. Avigdor Scherz discussed his recent breakthrough. Together with the late Prof. Yoram Salomon, Prof. Scherz invented a revolutionary, noninvasive approach to fight early-stage prostate cancer. To conclude the night, Jill Moskowitz, Mid-Atlantic Region Executive Director, spoke about strengthening and growing the Weizmann Institute’s community of supporters in Washington, D.C. and beyond. Marking the week of Yom Hazikaron and Yom Haatzmaut, she led guests in singing “Hatikvah.”

L-R: American Committee CEO Marshall S. Levin, Susan Heilig, Mid-Atlantic Executive Director Jill Moskowitz, and Gabriel Heilig.